Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile

Background: Chronic hepatitis C is an important health problem in Chile. In 2005, the Ministry of Health started a pilot treatment program with peg interferon and ribavirin, to be developed in public hospitals all over the country. Aim: To report the results ofhepatitis C treatment obtained at our i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aravena,Edmundo, Pinto,Andrea, Roblero,Juan Pablo, González Z,Marcela, Iturriaga,Hernán
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2012
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012001200002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872012001200002
record_format dspace
spelling oai:scielo:S0034-988720120012000022013-05-02Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en ChileAravena,EdmundoPinto,AndreaRoblero,Juan PabloGonzález Z,MarcelaIturriaga,Hernán Hepatitis C, chronic Peginterferon alfa-2a Peginterferon alfa-2b Ribavirin Background: Chronic hepatitis C is an important health problem in Chile. In 2005, the Ministry of Health started a pilot treatment program with peg interferon and ribavirin, to be developed in public hospitals all over the country. Aim: To report the results ofhepatitis C treatment obtained at our institution. Patients and Methods: Between 2005 and 2009, 63 patients were referred for treatment. In all, the viral load and genotype were determined. Peg interferon alpha-2a or alpha-2b plus ribavirin were used for therapy for up to 48 weeks in genotypes (G) 1 or 4 or 24 weeks in genotypes 2 or 3. If at the end oftreatment, viral load measured by polymerase chain reaction (PCR) was negative, it was repeated 6 months later. A negative viral load at that time was considered a sustained viral response (SVR). Results: Among the 51 patients who started treatment, 42 (80.4%) were G1,1 was G2,1 was G4 and 7 were G3. A SVR was reached in 51.1% ofG 1 and 4 and in 87.5% in G 3 and 2. In a univariate analysis, the variables significantly associated with a positive viral response were the degree offibrosis and body mass index. Conclusions: These results are similar to those obtained in other international series, demonstrating that Hispanic ethnicity does not influence the response to treatment. Our good results could be explained by the excellent compliance of the patients to the treatment. A higher degree offibrosis and a higher BMI were associated with a poor response.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.140 n.12 20122012-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012001200002es10.4067/S0034-98872012001200002
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Hepatitis C, chronic
Peginterferon alfa-2a
Peginterferon alfa-2b
Ribavirin
spellingShingle Hepatitis C, chronic
Peginterferon alfa-2a
Peginterferon alfa-2b
Ribavirin
Aravena,Edmundo
Pinto,Andrea
Roblero,Juan Pablo
González Z,Marcela
Iturriaga,Hernán
Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
description Background: Chronic hepatitis C is an important health problem in Chile. In 2005, the Ministry of Health started a pilot treatment program with peg interferon and ribavirin, to be developed in public hospitals all over the country. Aim: To report the results ofhepatitis C treatment obtained at our institution. Patients and Methods: Between 2005 and 2009, 63 patients were referred for treatment. In all, the viral load and genotype were determined. Peg interferon alpha-2a or alpha-2b plus ribavirin were used for therapy for up to 48 weeks in genotypes (G) 1 or 4 or 24 weeks in genotypes 2 or 3. If at the end oftreatment, viral load measured by polymerase chain reaction (PCR) was negative, it was repeated 6 months later. A negative viral load at that time was considered a sustained viral response (SVR). Results: Among the 51 patients who started treatment, 42 (80.4%) were G1,1 was G2,1 was G4 and 7 were G3. A SVR was reached in 51.1% ofG 1 and 4 and in 87.5% in G 3 and 2. In a univariate analysis, the variables significantly associated with a positive viral response were the degree offibrosis and body mass index. Conclusions: These results are similar to those obtained in other international series, demonstrating that Hispanic ethnicity does not influence the response to treatment. Our good results could be explained by the excellent compliance of the patients to the treatment. A higher degree offibrosis and a higher BMI were associated with a poor response.
author Aravena,Edmundo
Pinto,Andrea
Roblero,Juan Pablo
González Z,Marcela
Iturriaga,Hernán
author_facet Aravena,Edmundo
Pinto,Andrea
Roblero,Juan Pablo
González Z,Marcela
Iturriaga,Hernán
author_sort Aravena,Edmundo
title Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
title_short Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
title_full Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
title_fullStr Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
title_full_unstemmed Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
title_sort resultados del tratamiento de la hepatitis crónica por virus c en un hospital público, en chile
publisher Sociedad Médica de Santiago
publishDate 2012
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012001200002
work_keys_str_mv AT aravenaedmundo resultadosdeltratamientodelahepatitiscronicaporviruscenunhospitalpublicoenchile
AT pintoandrea resultadosdeltratamientodelahepatitiscronicaporviruscenunhospitalpublicoenchile
AT roblerojuanpablo resultadosdeltratamientodelahepatitiscronicaporviruscenunhospitalpublicoenchile
AT gonzalezzmarcela resultadosdeltratamientodelahepatitiscronicaporviruscenunhospitalpublicoenchile
AT iturriagahernan resultadosdeltratamientodelahepatitiscronicaporviruscenunhospitalpublicoenchile
_version_ 1718436663511744512